Skip to content
Politics
Prognosis

Pfizer-BioNTech Covid Shot Cleared for Adolescents in U.S.

  • Move sets stage for immunizing middle, high-school students
  • Dosing could begin in coming days after CDC advisory meeting
Video player cover image
U.S. Clears Pfizer-BioNTech Covid Shot for Adolescents
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared for use in younger teens in the U.S., paving the way for the mass vaccination of middle- and high-school students before the start of summer camps and the next school year.